ArticleAJOG global reports2025

Efficacy of regular prophylaxis with a plasma-derived von Willebrand factor/factor VIII concentrate with a 1:1 activity ratio in reducing heavy menstrual bleeding in girls/women with von Willebrand disease.

Csongor Kiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.